Clinical Trials Arena November 18, 2022
Srivani Venna

With Velocity’s support, Egin Research will expand its treatment areas for recruiting patients into clinical trials.

Integrated research site organisation Velocity Clinical Research has announced the acquisition of multi-site company Egin Research, marking its expansion into the UK.

With the expansion into Europe, Velocity now has 42 dedicated research locations.

The addition of the two sites of Egin Research increases Velocity’s site footprint in Europe to three, following its first purchase in Hamburg, Germany, in July this year.

Velocity Clinical Research Europe executive vice-president Dominic Clavell said: “The size and importance of the UK market for clinical research cannot be underestimated. There is a focus on clinical trial regulation reform in a post-Brexit...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Mergers & Acquisitions / JV, Trends
Challenges in Trial Access and Treatment for Women with Chronic Illnesses
Brainomix AI shows its worth in AZ pulmonary fibrosis trial
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
'From Interpretation to Action': Using CGM to Manage T2D
Oncology in 2024: The clinical trial trends reshaping the role of CROs

Share This Article